These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 38788195)
1. The prognostic impact of tumor location in nonmuscle-invasive bladder cancer patients undergoing transurethral resection: insights from a cohort study utilizing Chinese multicenter and SEER registries. Liu L; Li K; Wang SG; Wang J; Yao Z; Xie Y; Ji Z; Chen Z; Hu H; Chen H; Hu J; Hou Y; Liu Z; Li Y; Ding Y; Kuang Y; Xun Y; Hu J; Zhang J; Li H; Chong T; Bi J; Wang Z; Wang Y; Zhang P; Wei Q; Chen Z; Li L; Huang J; Liu Z; Chen K; Int J Surg; 2024 Sep; 110(9):5641-5651. PubMed ID: 38788195 [TBL] [Abstract][Full Text] [Related]
2. Thulium laser en bloc resection reduces recurrence rates in NMIBC patients with tumor diameters ≥3cm compared to transurethral resection: a non-randomized controlled study. Yao Z; Li Y; Ding Y; Hou Y; Hu J; Liu Z; Shi P; Hu H; Li F; Hu J; Song W; Song X; Chen K; Liu L; Liu Z BMC Cancer; 2024 Oct; 24(1):1239. PubMed ID: 39379837 [TBL] [Abstract][Full Text] [Related]
3. Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer. Tae BS; Jeong CW; Kwak C; Kim HH; Moon KC; Ku JH PLoS One; 2017; 12(12):e0189354. PubMed ID: 29244843 [TBL] [Abstract][Full Text] [Related]
4. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection. Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526 [TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis. Matsushita Y; Miyake M; Nishimura N; Nishimoto K; Fukuhara H; Kobayashi K; Oyama M; Inoue K; Matsuyama H; Fujimoto K; Miyake H Int J Clin Oncol; 2024 Feb; 29(2):205-212. PubMed ID: 38112832 [TBL] [Abstract][Full Text] [Related]
6. Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study). Kawai T; Matsuyama H; Kobayashi K; Ikeda A; Miyake M; Nishimoto K; Matsushita Y; Nishiyama H; Fujimoto K; Oyama M; Miyake H; Azuma H; Inoue K; Mitsui T; Kawakita M; Oyama C; Mizokami A; Abe T; Kuroiwa H; Kume H Int J Urol; 2024 Aug; 31(8):906-912. PubMed ID: 38695571 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and outcomes of transurethral resection versus radical cystectomy for muscle-infiltrating bladder cancer in the United States: A population-based cohort study. Zheng Y; Ye Y; Chen J; Wei Z; Liu Z; Yu K; Zhang X Int J Surg; 2022 Jul; 103():106693. PubMed ID: 35690361 [TBL] [Abstract][Full Text] [Related]
8. Impact on Japanese healthcare economics of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer: A multicenter retrospective cohort study. Nishimura N; Miyake M; Nakahama T; Miyamoto T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsumoto H; Matsuyama H; Fujii T; Hirao Y; Fujimoto K Int J Urol; 2023 Dec; 30(12):1112-1119. PubMed ID: 37605814 [TBL] [Abstract][Full Text] [Related]
9. The Impact of Restaging Transurethral Resection of Bladder Tumor on Survival Parameters in T1 Nonmuscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis. Krajewski W; Nowak Ł; Poletajew S; Tukiendorf A; Moschini M; Mari A; Di Trapani E; Xylinas E; Kiełb P; Wełna M; Zdrojowy R J Endourol; 2020 Aug; 34(8):795-804. PubMed ID: 32336149 [No Abstract] [Full Text] [Related]
10. Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor. Fujita N; Hatakeyama S; Momota M; Tobisawa Y; Yoneyama T; Yamamoto H; Imai A; Ito H; Yoneyama T; Hashimoto Y; Yoshikawa K; Ohyama C Urol Oncol; 2020 Oct; 38(10):795.e9-795.e17. PubMed ID: 32417111 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance and predictive capacity of early urine cytology after transurethral resection of nonmuscle invasive bladder cancer: A prospective study. Elsawy AA; Harraz AM; Ghobrial FK; Abdullatef M; Ali-El-Dein B Urol Oncol; 2020 Dec; 38(12):935.e1-935.e8. PubMed ID: 32654947 [TBL] [Abstract][Full Text] [Related]
12. Monopolar versus bipolar transurethral resection of bladder Tumour: post-hoc analysis of a prospective trial. Wong CH; Lim JY; Ko IC; Leung DK; Yuen SK; Yip SY; Ng CF; Teoh JY; Chan ES World J Urol; 2024 Aug; 42(1):466. PubMed ID: 39093420 [TBL] [Abstract][Full Text] [Related]
13. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking. Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM; BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434 [TBL] [Abstract][Full Text] [Related]
14. Preoperative Plasma Fibrinogen and D-dimer as Prognostic Biomarkers for Non-Muscle-Invasive Bladder Cancer. Li X; Shu K; Zhou J; Yu Q; Cui S; Liu J; Zhou R; Ding D Clin Genitourin Cancer; 2020 Feb; 18(1):11-19.e1. PubMed ID: 31787543 [TBL] [Abstract][Full Text] [Related]
15. Risks and benefits of transurethral resection of the bladder tumor using photodynamic diagnosis with oral 5-aminolevulinic acid hydrochloride according to age and history of recurrence in patients with non-muscle invasive bladder cancer. Kobayashi K; Matsuyama H; Oka S; Nakamura K; Misumi T; Hiroyoshi T; Ito H; Isoyama N; Hirata H; Matsumoto H; Shiraishi K Photodiagnosis Photodyn Ther; 2023 Mar; 41():103294. PubMed ID: 36681259 [TBL] [Abstract][Full Text] [Related]
16. Treatment Options for Signet Ring Cell Carcinoma of the Urinary Bladder: A Population-Based Study. Xie Y; Zhang Y; Du Z; Liu D; Yan W; Liu Y; Ping H Cancer Control; 2024; 31():10732748241278485. PubMed ID: 39159955 [TBL] [Abstract][Full Text] [Related]
17. Analysis of Risk Factors for Recurrence after Transurethral Resection of Bladder Tumor in Patients with Non-Muscle Invasive Bladder Cancer: 2-Year Follow-Up Outcomes. Li H; Wang L; Li H; Zhang P; Li Z; Xue L; Wang Z; Fu D; Chen Q; Luo Q; Chong T; Wang Z Oncology; 2024; 102(4):337-342. PubMed ID: 37647883 [TBL] [Abstract][Full Text] [Related]
18. Pelvic organ-preserving radical cystectomy versus standard radical cystectomy in female patients diagnosed with bladder cancer. Wang C; Zhang X World J Surg Oncol; 2024 Aug; 22(1):218. PubMed ID: 39182105 [TBL] [Abstract][Full Text] [Related]
19. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy. Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837 [TBL] [Abstract][Full Text] [Related]
20. Outcomes of stratified transurethral resection of bladder tumor: A propensity score-matched analysis. Huang WL; Huang CY; Huang KH; Pu YS; Chang HC; Chow PM J Formos Med Assoc; 2022 Jan; 121(1 Pt 1):73-80. PubMed ID: 33551309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]